-
<![CDATA[The Movement of Medicine: The Mindful Path of an MPN Giant]]>
26 Dec 2025 17:04 GMT
… ,” Tefferi explained. “Medicine is medicine. It doesn’t … diagnostics, prognostication, and treatment research and development. This … same for younger doctors and researchers entering … drugs that specifically target the cancer, much like imatinib …
-
Treatment paradigm shifts for ‘Ph+ ALL,’ but insurance coverage stuck for decades: expert
26 Dec 2025 09:04 GMT
… as imatinib (Gleevec) and ponatinib (Iclusig), has transformed the treatment landscape for … can now be expected from medication alone, even in elderly patients … any limitations or restrictions regarding drug use?
A: Ultimately, it…
-
Plastic waste transformed into building blocks for cancer drugs
20 Dec 2025 06:06 GMT
… blockbuster anticancer drug Imatinib, Tranexamic acid, the base for medication that helps … high-value APIs (Active Pharmaceutical Ingredients) and agrochemicals. Although … 2025). From Plastic Waste to Pharmaceutical Precursors: PET Upcycling Through …
-
Scientists make breakthrough discovery that could transform trash into building blocks for anti-cancer medication: 'We are excited'
20 Dec 2025 01:33 GMT
… polyester, blood clot medication, insecticide, and anticancer drug Imatinib.
"We … high-value APIs (Active Pharmaceutical Ingredients) and agrochemicals,… recycling plastic for medical purposes.
"Pharmaceutical manufacturing generates …
-
How Obesity Affects Drugs Used to Treat GI Cancers
16 Dec 2025 16:57 GMT
… imatinib, and sunitinib is decreased. Imatinib … .48 Medication Management and Pharmaceutical Expertise: … gastric cancers and statins for hepatocellular … Treatment strategies and pharmacist-led medication management for Helicobacter pylori infection. Drug …
-
Gastric Cancer Drugs Market to Reach US $7.35 Billion by 2029
10 Dec 2025 09:00 GMT
… • Otsuka Pharmaceutical
• Jiangsu HengRui Medicine
• Biocon … Biotech (India)
What Are The Prominent Trends In The Gastric Cancer Drugs … Drug Administration (FDA) in November 2023 for KEYTRUDA (pembrolizumab). This treatment … ) By Imatinib: Oral Formulations …
-
ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
09 Dec 2025 00:45 GMT
… line of TKIs (including imatinib, flumatinib, nilotinib, and … Medical Products Administration (NMPA) approval for the treatment … registrational Phase III trials: the FDA-cleared GLORA … with numerous leading biotechnology and pharmaceutical companies, such as …
-
Chemotherapy-free combination treatment outperforms traditional regimens in patients with Ph+ ALL
08 Dec 2025 02:49 GMT
… study. The phase III trial, which included adult patients … and chemotherapy.
For the trial, researchers enrolled 236 adult patients … group received the TKI imatinib along with either four … who had discontinued their treatment.
Complete remission was achieved …
-
<![CDATA[FDA and EMA Clear Phase 3 POLARIS-1 Trial in Newly Diagnosed Ph+ ALL]]>
06 Dec 2025 00:05 GMT
The FDA and European Medicines Agency (EMA) have cleared … day with chemotherapy or oral imatinib (Gleevec) once daily with … requiring systemic treatment.
The primary end point of the trial was … newly diagnosed Ph+ALL. Clinical Trials.gov. Updated November 7, …
-
<![CDATA[As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib]]>
03 Dec 2025 19:43 GMT
… Medicine published results in April 2001,1 and the FDA approved imatinib … be a randomized trial comparing the study drug with interferon-α, … individual patient characteristics for treatment decisions.8
A … had to convince a pharmaceutical partner to develop a …
About
© 1995-2025